Surrozen Presented Data Supporting Potential of SZN-1326 at the 2021 United European Gastroenterology Week

NEXT STORY
Merit Medical Systems to Announce Third Quarter Results on October 28, 2021
PREV STORY
First Watch Restaurant Group, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

23andMe Announces Extension of GSK Collaboration and Update on Joint Immuno-oncology Program

author_avatar
NASDAQ Market News

FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease

author_avatar
NASDAQ Market News

CORRECTING and REPLACING – Precision Therapeutics Releases Highlights from FY 2017 Business Update Call

author_avatar
NASDAQ Market News